Center for Common Disease Genomics [CCDG] - Cardiovascular: The Bangladesh Risk of Acute Vascular Events (BRAVE) Study

Description

The Bangladesh Risk of Acute Vascular Events (BRAVE) study is a hospital-based case-control study in Bangladesh which was established by the Cardiovascular Epidemiology Unit of Cambridge University in the UK in partnership with the key local cardiology and research centres to examine environmental, genetic, lifestyle and biochemical determinants of myocardial infarction (MI) among this South Asian population. By the end of 2016, this study has recruited ~8000 clinically confirmed first-ever MI cases (with a significant proportion being early-onset MI), and ~8000 healthy controls frequency-matched by age and sex. This site hosts data from ~500 whole genomes and ~1500 whole exomes (50% cases and 50% controls)

Stats

2Cohorts

1,992Samples

1,992Participants

8.81 TBSize

Summary

Consent Codes

Diseasesmyocardial infarction

AccessControlled Access

Study DesignCase-Control, TBD

Data TypesWhole Genome, Exome

Applying For Access

dbGaP FAQ dbGaP Access Request Video Tutorial

Terra Workspaces

This study has been divided into the following workspaces by consent codes and optionally the originating laboratory.

Terra Workspace Name	Consent Code	Disease	Access	Study Design	Data Type	Samples	Participants	Size (TB)
AnVIL_CCDG_Broad_CVD_Stroke_BRAVE_WGS	GRU	myocardial infarction	Controlled Access	Case-Control	Whole Genome	496	496	6.34
AnVIL_CCDG_Broad_MI_BRAVE_GRU_WES	GRU	myocardial infarction	Controlled Access	TBD	Exome	1,496	1,496	2.47